Christine Ghobrial
About Christine Ghobrial
Christine Ghobrial is the Director, WW Commercial at Bristol Myers Squibb, specializing in GI Tumors with over 15 years of experience in strategic roles.
Current Position at Bristol Myers Squibb
Christine Ghobrial is currently serving as the Director of Worldwide Commercial at Bristol Myers Squibb. In her role, she specializes in gastrointestinal (GI) tumors, directing commercial strategies to support the company's global healthcare initiatives. Her responsibilities include overseeing commercial planning and execution, contributing to her reputation as a seasoned leader in the pharmaceutical industry.
Previous Roles at Bristol Myers Squibb
Christine Ghobrial has an extensive history at Bristol Myers Squibb, holding multiple strategic and leadership positions. Before her current role, she was the Senior Director of Worldwide Market Access Strategy for 7 months from 2021 to 2022. From 2019 to 2021, she served as the Director of Worldwide Market Access Strategy. Additionally, her tenure includes roles as Associate Director for both Worldwide Access Execution and US Payer Marketing. She started her journey at the company as Manager/Senior Manager of US Medical Information, climbing the ranks through various impactful positions.
Educational Background
Christine Ghobrial completed her higher education at Rutgers University, where she earned dual degrees: a Doctor of Pharmacy (PharmD) and a Master of Business Administration (MBA). Her academic background combines pharmaceutical expertise with business acumen, forming a strong foundation for her leadership roles in the pharmaceutical industry.
Experience and Expertise
With over 15 years of experience at Bristol Myers Squibb, Christine Ghobrial has developed extensive expertise in market access, payer marketing, and medical strategy. Her focus areas have included US Payer Marketing, Global Medical Strategy and Innovation, and Worldwide Market Access. This diverse portfolio of roles has allowed her to cultivate a comprehensive understanding of both domestic and global healthcare markets.
Specialization in GI Tumors
In her current role as Director of Worldwide Commercial, Christine Ghobrial specializes in gastrointestinal (GI) tumors. This specialization involves developing and implementing strategic initiatives to enhance the commercial success of Bristol Myers Squibb’s GI tumor treatments. Her expertise in this area is a testament to her capability in managing complex medical and commercial landscapes.